[Triamcinolone acetonide in the prevention of experimental proliferative vitreoretinopathy].
Macrophages were used to induce an experimental model of proliferative vitreoretinopathy (PVR) for the evaluation of drug efficacy of triamcinolone acetonide in the prevention of PVR. After injection of macrophages into the rabbit vitreous, 1 mg of triamcinolone and 0.1 ml saline, respectively, were also injected into the vitreous of the treated group and the control group. Afterwards, on the 28th day, retinal detachment developed in 77% of the eyes in the control group and in 13% of the eyes in the treated group (n = 30, P < 0.01). The time of triamcinolone being cleared up from the vitreous was 35-63 days (average 45.5 days). Electroretinogram and transmission electron microscopic examinations demonstrated that up to 4 mg of triamcinolone was nontoxic to the retina. The results suggest that during inflammatory stage, the use of triamcinolone effectively and safely prevent the development of PVR.
Liang
H C
HC
Department of Ophthalmology, Xijing Hospital 4th Military Medical University, Xi-an.
Hui
Y N
YN
Cai
Y S
YS
D000818:Animals; D005260:Female; D008297:Male; D011817:Rabbits; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D018630:Vitreoretinopathy, Proliferative / Q000517:prevention & control*
D014222:Triamcinolone Acetonide